<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>Reporter for Nature, mostly covering biology and medicine. &#xA;Probably has more Nature publications than you😁. &#xA;hledford.01 (Signal) and heidiledford (@proton.me)</description><link>https://bsky.app/profile/heidiledford.bsky.social</link><title>@heidiledford.bsky.social - Heidi Ledford</title><item><link>https://bsky.app/profile/heidiledford.bsky.social/post/3mvl7ljzf2k25</link><description>Food poisoning bug sends immune cells charging from the gut to the brain -- fun, fascinating story by @gvconroy.bsky.social @nature.com &#xA;https://www.nature.com/articles/d41586-026-02891-w</description><pubDate>15 Sep 2026 18:04 +0000</pubDate><guid isPermaLink="false">at://did:plc:bqua2klhrnddcdnpnsypwzyk/app.bsky.feed.post/3mvl7ljzf2k25</guid></item><item><link>https://bsky.app/profile/heidiledford.bsky.social/post/3mvb2oydjpc2v</link><description>Really enjoyed this @jesshamzelou.bsky.social roundup of under-35s to watch in biotech. A timely reminder (just ahead of Nobel season!) for folks like me to not just focus on the senior investigators... 🧪&#xA;https://www.technologyreview.com/2026/09/11/1143834/meet-the-under-35s-shaping-the-future-of-biotech/</description><pubDate>11 Sep 2026 17:10 +0000</pubDate><guid isPermaLink="false">at://did:plc:bqua2klhrnddcdnpnsypwzyk/app.bsky.feed.post/3mvb2oydjpc2v</guid></item><item><link>https://bsky.app/profile/heidiledford.bsky.social/post/3mvauw25uss2y</link><description>Did an experimental cell therapy rebuild bones in people with osteoporosis? &#xA;Elie Dolgin balances hope and caveats in this @nature.com story about a small, preliminary clinical trial of marrow cells that were modified to seek out bone &#xA;https://www.nature.com/articles/d41586-026-02828-3</description><pubDate>11 Sep 2026 15:27 +0000</pubDate><guid isPermaLink="false">at://did:plc:bqua2klhrnddcdnpnsypwzyk/app.bsky.feed.post/3mvauw25uss2y</guid></item><item><link>https://bsky.app/profile/heidiledford.bsky.social/post/3mukxmqnows2s</link><description>A landmark pancreatic cancer drug is showing promise against the world’s biggest cancer killer: lung cancer.&#xA;&#xA;It’s early days – the clinical trial was small, and drug resistance remains a problem – but I&#39;ll take good news where I can find it. &#xA;https://www.nature.com/articles/d41586-026-02745-5</description><pubDate>02 Sep 2026 22:17 +0000</pubDate><guid isPermaLink="false">at://did:plc:bqua2klhrnddcdnpnsypwzyk/app.bsky.feed.post/3mukxmqnows2s</guid></item><item><link>https://bsky.app/profile/heidiledford.bsky.social/post/3mo4pt3s32c2r</link><description>Not just an issue for AI:&#xA;&#xA;&#34;Scientists and engineers who build powerful AI systems often understand the tools’ capabilities in extraordinary detail. What they resist — and sometimes cannot see — is that their technical choices are also political choices.&#34;&#xA;https://www.nature.com/articles/d41586-026-01876-z</description><pubDate>12 Jun 2026 21:49 +0000</pubDate><guid isPermaLink="false">at://did:plc:bqua2klhrnddcdnpnsypwzyk/app.bsky.feed.post/3mo4pt3s32c2r</guid></item><item><link>https://bsky.app/profile/heidiledford.bsky.social/post/3mhekdtvcbc2i</link><description>Ouch.&#xA;&#xA;“Despite the incredible wealth of interesting content at conferences, it can be hard to stay engaged. And by engaged, I mean awake.&#34;&#xA;&#xA;https://www.nature.com/articles/d41586-026-00854-9</description><pubDate>18 Mar 2026 22:36 +0000</pubDate><guid isPermaLink="false">at://did:plc:bqua2klhrnddcdnpnsypwzyk/app.bsky.feed.post/3mhekdtvcbc2i</guid></item></channel></rss>